Metilendioksimetamfetamin (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metilendioksimetamfetamin" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

8doi.org

2^nd place

7nih.gov

4^th place

3^rd place

5erowid.org

3,887^th place

1,856^th place

4web.archive.org

1^st place

2wikipedia.org

low place

1sciencedirect.com

149^th place

32^nd place

1jcheminf.com

low place

33^rd place

1dot.gov

1,690^th place

5,281^st place

1who.int

195^th place

70^th place

1ecstasy.org

low place

1addictionjournal.org

low place

1betweenthelines.net.au

low place

1betterhealth.vic.gov.au

low place

1mydr.com.au

low place

9,930^th place

1archive.org

6^th place

5^th place

addictionjournal.org

Addiction (February 2011) "New study finds no cognitive impairment among ecstasy users" Arhivirano 2011-07-12 na Wayback Machine-u

archive.org

Verheyden SL, Henry JA, Curran HV (2003). „Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users”. Hum Psychopharmacol 18 (7): 507–17. DOI:10.1002/hup.529. PMID 14533132.

betterhealth.vic.gov.au

„Ecstasy”. betterhealth.vic.gov.au. Arhivirano iz originala na datum 2014-04-26. Pristupljeno 25. 5. 2010.

betweenthelines.net.au

„Ecstasy basics”. betweenthelines.net.au. Arhivirano iz originala na datum 2012-10-28. Pristupljeno 25. 5. 2010.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Bernschneider-Reif S, Oxler F, Freudenmann RW (November 2006). „The Origin of MDMA ("Ecstasy")--Separating the Facts From the Myths.”. Pharmazie 61 (11): 966–972. DOI:10.1111/j.1360-0443.2006.01511.x. PMID 17152992.
Liechti ME, Gamma A, Vollenweider FX (2001). „Gender Differences in the Subjective Effects of MDMA”. Psychopharmacology 154 (2): 161–168. DOI:10.1007/s002130000648. PMID 11314678.
Hardman HF, Haavik CO, Seevers MH (1973). „Relationship of the Structure of Mescaline and Seven Analogs to Toxicity and Behavior in Five Species of Laboratory Animals”. Toxicology Applied Pharmacology 25 (2): 299–309. DOI:10.1016/S0041-008X(73)80016-X. PMID 4197635.
Verheyden SL, Henry JA, Curran HV (2003). „Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users”. Hum Psychopharmacol 18 (7): 507–17. DOI:10.1002/hup.529. PMID 14533132.
Verheyden SL, Maidment R, Curran HV (2003). „Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health”. J. Psychopharmacol. (Oxford) 17 (4): 371–8. DOI:10.1177/0269881103174014. PMID 14870948.

dot.gov

nhtsa.dot.gov

„Methylenedioxymethamphetamine (MDMA, ecstasy)”. Drugs and Human Performance Fact Sheets.. National Highway Traffic Safety Administration. Arhivirano iz originala na datum 2012-05-03. Pristupljeno 2014-04-05.

ecstasy.org

E for Ecstasy by Nicholas Saunders, Appendix 1: Reference Section. Ecstasy.org. Retrieved on 2011-06-11.

erowid.org

Bernschneider-Reif S, Oxler F, Freudenmann RW (November 2006). „The Origin of MDMA ("Ecstasy")--Separating the Facts From the Myths.”. Pharmazie 61 (11): 966–972. DOI:10.1111/j.1360-0443.2006.01511.x. PMID 17152992.
Liechti ME, Gamma A, Vollenweider FX (2001). „Gender Differences in the Subjective Effects of MDMA”. Psychopharmacology 154 (2): 161–168. DOI:10.1007/s002130000648. PMID 11314678.
Erowid (September 2001). Short-Term Side Effects of MDMA.
Hardman HF, Haavik CO, Seevers MH (1973). „Relationship of the Structure of Mescaline and Seven Analogs to Toxicity and Behavior in Five Species of Laboratory Animals”. Toxicology Applied Pharmacology 25 (2): 299–309. DOI:10.1016/S0041-008X(73)80016-X. PMID 4197635.
„MDMA Basics”. erowid.org. Pristupljeno 25. 5. 2010.

jcheminf.com

Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

mydr.com.au

„Ecstasy: effects on the body”. ydr.com.au. Pristupljeno 25. 5. 2010.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Bernschneider-Reif S, Oxler F, Freudenmann RW (November 2006). „The Origin of MDMA ("Ecstasy")--Separating the Facts From the Myths.”. Pharmazie 61 (11): 966–972. DOI:10.1111/j.1360-0443.2006.01511.x. PMID 17152992.
Liechti ME, Gamma A, Vollenweider FX (2001). „Gender Differences in the Subjective Effects of MDMA”. Psychopharmacology 154 (2): 161–168. DOI:10.1007/s002130000648. PMID 11314678.
Hardman HF, Haavik CO, Seevers MH (1973). „Relationship of the Structure of Mescaline and Seven Analogs to Toxicity and Behavior in Five Species of Laboratory Animals”. Toxicology Applied Pharmacology 25 (2): 299–309. DOI:10.1016/S0041-008X(73)80016-X. PMID 4197635.
Verheyden SL, Henry JA, Curran HV (2003). „Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users”. Hum Psychopharmacol 18 (7): 507–17. DOI:10.1002/hup.529. PMID 14533132.
Verheyden SL, Maidment R, Curran HV (2003). „Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health”. J. Psychopharmacol. (Oxford) 17 (4): 371–8. DOI:10.1177/0269881103174014. PMID 14870948.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

web.archive.org

„Methylenedioxymethamphetamine (MDMA, ecstasy)”. Drugs and Human Performance Fact Sheets.. National Highway Traffic Safety Administration. Arhivirano iz originala na datum 2012-05-03. Pristupljeno 2014-04-05.
Addiction (February 2011) "New study finds no cognitive impairment among ecstasy users" Arhivirano 2011-07-12 na Wayback Machine-u
„Ecstasy basics”. betweenthelines.net.au. Arhivirano iz originala na datum 2012-10-28. Pristupljeno 25. 5. 2010.
„Ecstasy”. betterhealth.vic.gov.au. Arhivirano iz originala na datum 2014-04-26. Pristupljeno 25. 5. 2010.

who.int

whqlibdoc.who.int

22nd report of the Expert Committee on Drug Dependence World Health Organization, 1985], Pristupljeno 11. 4. 2013.

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit